Primary record
2-(4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4-dihydrophthalazin-1-yl)acetic acid
- 库存
- 3,759 克
- 纯度
- 99.5 %
- CAS
- 110703-94-1
化合物标识与属性
- CAS
- 110703-94-1
- PubChem CID
- 1613
- SMILES
- C1=CC=C2C(=C1)C(=NN(C2=O)CC3=NC4=C(S3)C=CC(=C4)C(F)(F)F)CC(=O)O
- Canonical SMILES
- O=C(O)Cc1nn(Cc2nc3cc(C(F)(F)F)ccc3s2)c(=O)c2ccccc12
名称与同义词
- ZOPOLRESTAT
- Alond
- Zopolrestatum
- Xedia
- Zopalrestat
- 110703-94-1
- 4kyh
- Zopolrestatum [INN-Latin]
- ACMC-20cjtz
- Alond (TN)
- 1PV3S9WP3D
- CP-73850
- UNII-1PV3S9WP3D
- C19H12F3N3O3S
- AC1L1BUL
- AC1Q4JNJ
- CP 73850
- ZOPOLRESTAT [MI]
- RefChem:905383
- ZOPOLRESTAT [INN]
- Zopolrestat (USAN/INN)
- ZOPOLRESTAT [USAN]
- CHEMBL10372
- D06EDT
- DTXSID80149365
- Zopolrestat [USAN:BAN:INN]
- Zopolrestat [USAN:INN:BAN]
- BCSVCWVQNOXFGL-UHFFFAOYSA-N
- #REF!
- SCHEMBL49012
- 4-Fluoro-3-methylbenzylamine
- ZOPOLRESTAT [WHO-DD]
- MLS006010619
- GTPL7419
- orb1304115
- DTXCID3071856
- SCHEMBL29353641
- BDBM16452
- CTK0H6574
- Zopolrestat, >=98% (HPLC)
- CID1613
- CP-73,850
- MFCD00865476
- ZINC538557
- CID:1613
- AR-1E9178
- AKOS040754579
- DB08772
- EBC-499076
- C19-H12-F3-N3-O3-S
- DA-72363
- HY-19687
- MS-27339
- R991
- SMR002529706
- 2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid
- SID:112379023
- J360.579E
- LS-172134
- 1-Phthalazineaceticacid, 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-
- CS-0016207
- NS00068308
- 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid
- C01865
- D02328
- G12704
- A936736
- C067172
- 2-(4-oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrophthalazin-1-yl)acetic acid
- 3,4-Dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-1-phthalazineacetic acid
- 3,4-dihydro-4-oxo-3-((5-trifluoromethyl-2-benzothiazolyl)methyl)-1-phthalazine acetic acid
- BRD-K47710001-001-01-1
- Q27089300
- (4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4-dihydrophthalazin-1-yl)acetic acid
- 1-Phthalazineacetic acid, 3,4-dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-
- 3,4-dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-1-phthalazine-acetic acid
- B0084-358923
- 3-[(5-Trifluoromethyl-2-benzothiazolyl)methyl]-3,4-dihydro-4-oxophthalazine-1-acetic acid
- 1-Phthalazineacetic acid, 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-
- 2-(4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4-dihydrophthalazin-1-yl)acetic acid
- ZST
- [4-oxo-(5-trifluoromethyl-benzothiazol-2-ylmethyl)-3,4-dihydro-phthalazin-1-yl]-acetic acid
- 2-(4-oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)phthalazin-1-yl)acetic acid
- 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-phthalazin-1-ylacetic acid
- 3-[5-(Trifluoromethyl)benzothiazole-2-ylmethyl]-4-oxo-3,4-dihydrophthalazine-1-acetic acid
- 111944-83-3
- 2-[4-oxo-3-[5-(trifluoromethyl)benzothiazol-2-ylmethyl]-3,4-dihydrophthalazin-1-yl]acetic acid
- 682-922-9